⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30487642 | 0.87 | CA2 (0.50) | — | |
| SCHEMBL14555164 | 0.87 | CA2 (0.50) | — | |
| SCHEMBL7903813 | 0.86 | — | — | |
| SCHEMBL7951038 | 0.86 | TSHR (0.61) | — | |
| SCHEMBL28644407 | 0.84 | TSHR (0.53) | — | |
| Hydrochloric Acid SCHEMBL27759642 | 0.84 | TSHR (0.59) | — | |
| SCHEMBL21783982 | 0.82 | TSHR (0.52) | — | |
| SCHEMBL27726587 | 0.81 | TDP1 (0.46) | — | |
| SCHEMBL8958454 | 0.79 | CA2 (0.50) | — | |
| SCHEMBL6468831 | 0.79 | GAA (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028333-A1 | NEW COMPOUNDS | VICORE PHARMA AB (SE) | 2026-01-29 | — | — | US | claimed |
| US-20220388994-A1 | NEW COMPOUNDS | VICORE PHARMA AB (SE) | 2022-12-08 | — | — | US | claimed |
| EP-4031240-A1 | NEW COMPOUNDS | Vicore Pharma AB (SE) | 2022-07-27 | — | — | EP | claimed |
| CN-114786774-A | Novel compounds | 维科尔药物公司 | 2022-07-22 | — | — | CN | claimed |
| CN-109923114-A | Pyrazolopyridine derivatives as HPK1 modulators and their use for the treatment of cancer | 因赛特公司 | 2019-06-21 | — | — | CN | claimed |
| EP-2488503-A1 | AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON | Myrexis, Inc. (US) | 2012-08-22 | — | — | EP | claimed |
| CN-1993333-B | Triazole derivatives | TAISHO PHARMACEUTICAL CO LTD | 2012-08-01 | — | — | CN | claimed |
| US-8022225-B2 | Triazole derivative | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2011-09-20 | — | — | US | claimed |
| WO-2011046970-A1 | AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON | MYREXIS, INC. (US) | 2011-04-21 | — | — | WO | claimed |
| CN-1335836-A | Tricyclic pyrazole derivatives | BASF AG (DE) | 2002-02-13 | — | — | CN | claimed |
| EP-0085286-B1 | PARA-SUBSTITUTED 3-PHENOXY-1-CARBONYLAMINOALKYLAMINO-PROPAN-2-OLS HAVING BETA RECEPTOR BLOCKING PROPERTIES | Aktiebolaget Hässle (SE) | 1986-04-30 | — | — | EP | claimed |
| US-20260028333-A1 | NEW COMPOUNDS | VICORE PHARMA AB (SE) | 2026-01-29 | — | — | US | disclosed |
| US-20250304576-A1 | IKK INHIBITORS | CANCER RESEARCH TECH LTD (GB) | 2025-10-02 | — | — | US | disclosed |
| EP-4171563-B1 | TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS | BOEHRINGER INGELHEIM INT (DE) | 2025-08-06 | — | — | EP | disclosed |
| CN-119841829-A | Compounds for the treatment of PI3K gamma mediated diseases and uses thereof | 中国科学院合肥物质科学研究院 | 2025-04-18 | — | — | CN | disclosed |
| US-4952483-A | NOVEL HYDRAZINE NUCLEATING AGENTS AND ACCELERATORS | FUJI PHOTO FILM CO., LTD. (JP) | 1990-08-28 | — | — | US | disclosed |
| US-4871653-A | DEVELOPING IN PRESENCE OF MERCAPTO POLYAZAINDENE PROMOTERS AND NUCLEATING QUATERNARY OR HYDRAZIDE-TYPE COMPOUNDS | FUJI PHOTO FILM CO., LTD. (JP) | 1989-10-03 | — | — | US | disclosed |
| EP-0283041-A1 | Direct positive silver halide photosensitive material and method for forming direct positive image | FUJI PHOTO FILM CO., LTD. (JP) | 1988-09-21 | — | — | EP | disclosed |
| US-4631138-A | TRIAZONES AND TRIAZINE THIONES FOR USE WITH OIL AND GAS WELL DRILLING EQUIPMENT | PETROLITE CORPORATION (US) | 1986-12-23 | — | — | US | disclosed |
| EP-0054817-A2 | Process for the continuous thermal decomposition of esters of carbamic acids and use of mixtures of esters of carbamic acids and isocyanates obtained by this process for the preparation of isocyanates | BAYER AG (DE) | 1982-06-30 | — | — | EP | disclosed |